Xifaxan for IBS-D: How It Works & Treats Symptoms

Irritable bowel syndrome with diarrhea, known as IBS-D, affects millions of people worldwide. This chronic condition causes recurring abdominal pain, bloating, and frequent loose stools that can significantly impact daily life. While various treatments exist, Xifaxan (rifaximin) has emerged as an important therapeutic option for adults with IBS-D.

Xifaxan represents a unique approach to treating IBS-D. Unlike traditional antibiotics that work throughout the body, rifaximin stays primarily in the digestive tract, where it can target bacteria without causing widespread systemic effects. This targeted action makes it particularly suitable for treating gut-related conditions like IBS-D.

What Is Xifaxan and How Does It Work?

Xifaxan (rifaximin) is a minimally absorbed antibiotic that works specifically in the intestines. The medication belongs to a class called rifamycin antibiotics, but it has been specially formulated to remain largely in the digestive tract rather than entering the bloodstream.

For IBS-D treatment, doctors believe rifaximin works by reducing harmful bacteria in the small intestine that may contribute to symptoms. Some research suggests that an overgrowth of certain bacteria in the small intestine, called small intestinal bacterial overgrowth or SIBO, may play a role in IBS-D symptoms. By targeting these bacteria, Xifaxan may help restore a healthier balance in the gut.

The medication received FDA approval for treating IBS-D in adults based on clinical trials showing it can provide lasting symptom relief even after completing a short treatment course.

Clinical Evidence: The TARGET Trials

The effectiveness of Xifaxan for IBS-D has been demonstrated in rigorous clinical studies called the TARGET trials. These large-scale studies compared rifaximin to a placebo in adults with IBS-D symptoms.

In the pivotal TARGET 1 and 2 trials, researchers gave participants either Xifaxan 550 mg three times daily or a placebo for 14 days. The studies measured whether patients experienced adequate relief of their global IBS symptoms, including abdominal pain and abnormal stool consistency or frequency.

Results showed that significantly more patients taking Xifaxan experienced symptom relief compared to those taking a placebo. Importantly, this improvement persisted for weeks after completing the antibiotic course, suggesting that rifaximin produces lasting changes in gut bacteria.

A subsequent study called TARGET 3 evaluated repeat treatment with rifaximin for patients whose symptoms returned after initial improvement. This research provided evidence that additional courses of Xifaxan can be safely and effectively used when symptoms recur.

Symptom-Specific Benefits

Recent analysis of the TARGET trial data provides detailed insight into how rifaximin affects individual IBS-D symptoms. The research examined multiple concurrent symptoms, including abdominal pain, bloating, and fecal urgency.

Patients taking rifaximin showed significant improvement across multiple symptom areas simultaneously. Benefits became evident within one week after completing treatment and were sustained for several weeks, demonstrating the durability of rifaximin’s effects.

How Xifaxan Is Prescribed for IBS-D

The standard dosing regimen for Xifaxan in IBS-D treatment is 550 mg taken three times daily for 14 days. This represents a complete course of treatment, after which patients typically stop taking the medication and monitor their symptoms.

Unlike chronic medications that require daily use, Xifaxan is prescribed in intermittent courses. Many patients experience symptom relief that lasts for months after completing a 14-day course. If symptoms return, doctors may prescribe additional courses as needed.

The medication comes in tablet form and should be taken with or without food as directed by your healthcare provider. It’s important to complete the full 14-day course even if symptoms improve before finishing all tablets.

Who Should Consider Xifaxan Treatment

Xifaxan may be appropriate for adults with IBS-D who experience recurring symptoms that interfere with daily activities. The medication is typically considered when other treatments like dietary changes, probiotics, or over-the-counter medications haven’t provided adequate relief.

Your doctor will evaluate your specific symptoms, medical history, and previous treatments to determine if rifaximin is a good option. The medication has been studied specifically in adults with IBS-D, so its use in other populations may not be appropriate.

Expected Benefits and Timeline

Patients taking Xifaxan for IBS-D can expect to see improvements in several key symptom areas. Clinical trials show that the medication helps reduce abdominal pain, improve stool consistency, and decrease the urgency associated with bowel movements.

The timeline for improvement typically follows this pattern:

• During treatment: Some patients notice initial changes in symptoms.
• Week 1 after completion: Benefits become more apparent.
• Weeks 2-4 after completion: Maximum benefit often achieved.
• Months 1-6 after completion: Sustained improvement in many patients.

Not all patients respond to rifaximin treatment. Clinical trials showed that approximately 40% of patients experienced significant symptom relief compared to about 30% taking a placebo. This means rifaximin provides meaningful benefit beyond placebo effects, though individual responses vary.

Side Effects and Safety Considerations

Xifaxan is generally well-tolerated, with most side effects being mild and temporary. Because the medication stays primarily in the digestive tract rather than entering the bloodstream, it causes fewer systemic effects than traditional antibiotics.

Common Side Effects

The most frequently reported side effects in clinical trials include:

• Nausea (occurring in about 4% of patients)
• Increase in liver enzymes (about 3% of patients)
• Dizziness (about 3% of patients)
• Fatigue (about 2% of patients)
• Ascites or fluid retention (about 2% of patients)

Most of these effects are mild and resolve on their own without requiring treatment discontinuation.

Serious but Rare Side Effects

While uncommon, some patients may experience more serious side effects that require immediate medical attention:

• Severe diarrhea that persists or worsens
• Signs of Clostridioides difficile infection (C. diff)
• Significant increases in liver function tests
• Allergic reactions, including rash, itching, or swelling

Patients with severe liver problems should use rifaximin with caution, as the medication may not be processed normally in cases of significant liver impairment.

Drug Interactions and Precautions

Rifaximin has fewer drug interactions than many antibiotics because it’s minimally absorbed into the bloodstream. However, some interactions can still occur, particularly with medications that are processed by the same liver enzymes.

Important considerations include:

• Blood-thinning medications like warfarin may need monitoring
• Some immunosuppressive drugs may interact with rifaximin
• Patients taking multiple medications should review their full medication list with their doctor

Always inform your healthcare provider about all medications, supplements, and herbal products you’re taking before starting Xifaxan treatment.

Cost and Insurance Coverage

The cost of Xifaxan can vary significantly depending on insurance coverage. As a brand-name medication, rifaximin may be expensive without insurance. Many insurance plans cover Xifaxan for FDA-approved uses like IBS-D, though prior authorization may be required.

For patients facing high out-of-pocket costs, several options may help reduce expenses. Manufacturer patient assistance programs may be available for qualifying individuals. Additionally, patients can explore safe, reliable cash-pay options through Universal Drugstore, which may offer competitive pricing for those paying without insurance.

When discussing cost concerns with your doctor, they may be able to provide information about patient assistance programs or alternative treatment options that fit your budget.

Repeat Treatment and Long-Term Use

One of the unique aspects of Xifaxan treatment is its intermittent dosing schedule. Unlike daily medications, rifaximin is taken as a 14-day course with breaks in between.

Research shows that repeat courses can be safely used when symptoms return. The TARGET 3 trial specifically studied patients who initially responded to rifaximin and then experienced symptom recurrence, finding that additional courses maintained safety and effectiveness.

The timing between courses varies among patients. Some may go months or even longer before needing repeat treatment, while others may require more frequent courses. Your doctor will work with you to determine the optimal retreatment schedule based on your symptom patterns and response.

Comparing Xifaxan to Other IBS-D Treatments

Xifaxan represents one option among several approaches to managing IBS-D. Understanding how it fits into the broader treatment landscape can help patients and doctors make informed decisions.

Other IBS-D treatments include:

• Dietary modifications like the low-FODMAP diet
• Antidiarrheal medications like loperamide
• Antispasmodic medications for abdominal pain
• Bile acid binders for specific types of diarrhea
• Probiotics to support gut health
• Psychological therapies for stress-related symptoms

Xifaxan’s unique advantage is its ability to provide lasting symptom relief with intermittent dosing. While daily medications require ongoing use, rifaximin courses may provide extended periods of symptom control. This can be particularly appealing for patients who prefer not to take daily medications or who haven’t found adequate relief with other approaches.

What to Expect During Treatment

Starting Xifaxan treatment involves several important steps to ensure safety and effectiveness. Your doctor will review your medical history, current medications, and specific IBS-D symptoms before prescribing rifaximin.

During the 14-day treatment course:

• Take tablets as prescribed, typically three times daily
• Continue your normal diet unless advised otherwise
• Monitor for any side effects or unusual symptoms
• Complete the full course even if symptoms improve early
• Keep track of symptom changes to discuss with your doctor

After completing treatment, continue monitoring your symptoms for several weeks. Many patients notice gradual improvement over the first month after finishing rifaximin. Keep a symptom diary to help track changes and determine when or if additional treatment might be needed.

Who Should Avoid Xifaxan

While Xifaxan is generally safe for most adults with IBS-D, certain individuals should avoid or use the medication with extreme caution. Patients with known allergies to rifaximin or related antibiotics should not take this medication.

People with severe liver disease may need alternative treatments, as rifaximin processing can be affected by significant liver impairment. Your doctor will evaluate liver function if there are concerns about your ability to safely use rifaximin.

Pregnant or breastfeeding women should discuss the risks and benefits of rifaximin treatment with their healthcare provider, as safety data in these populations is limited.

Making an Informed Decision

Deciding whether Xifaxan is right for your IBS-D treatment requires careful consideration of multiple factors. The medication offers a unique approach with the potential for lasting symptom relief through intermittent courses rather than daily medication use.

Consider discussing rifaximin with your doctor if:

• You have moderate to severe IBS-D symptoms
• Other treatments haven’t provided adequate relief
• You prefer intermittent treatment over daily medications
• Your symptoms significantly impact daily activities

Your healthcare provider can evaluate your specific situation, review potential benefits and risks, and help determine whether Xifaxan fits into your overall IBS-D management plan. Remember that effective IBS-D treatment often involves a combination of approaches, and rifaximin may work best when combined with appropriate dietary and lifestyle modifications.

References

• Lacy BE, Chang L, Rao SSC, Heimanson Z, Sayuk GS. Rifaximin Treatment for Individual and Multiple Symptoms of Irritable Bowel Syndrome With Diarrhea: An Analysis Using New End Points. Clin Ther. 2023 Mar;45(3):198-209. Accessed June 28, 2026.
• Xifaxan– rifaximin tablet [package insert]. Salix Pharmaceuticals, Inc. Last updated 10/2023. Accessed June 28, 2026.